96-Well Sitting-Drop Vapor Diffusion Sparse-Matrix Crystallization Screen for a Purified Soluble Protein Target

Two protein concentrations (5 and 10 mg/mL) are screened in parallel against one 96-condition commercial sparse-matrix screen (e.g., a Crystal Screen HT-type kit), giving 192 experimental drops. Each drop is set at a 1:1 protein:reservoir ratio (0.2 µL + 0.2 µL) using a sitting-drop 96-well 3-subwell plate; a second subwell receives a 2:1 ratio (0.3 µL + 0.15 µL) to broaden the supersaturation space. Plates are sealed and incubated at a single controlled temperature (18 C) with a parallel duplicate plate at 4 C to capture temperature-dependent nucleation. Drops are imaged at t = 0 h, 1 d, 3 d, 7 d, 14 d, and 28 d. No randomization is needed (screen positions are fixed), but plate orientation is recorded to deconvolve edge effects.

BSL-1 for a non-pathogenic recombinant protein. Hazards are chemical: many reservoir solutions contain irritants and toxicants (e.g., concentrated ammonium sulfate, organic precipitants, sodium azide as preservative, MPD, isopropanol, and some contain cacodylate which carries arsenic). Wear nitrile gloves, safety glasses, and a lab coat; handle in a ventilated area. Cacodylate- and azide-containing solutions are collected as hazardous chemical waste, never down the drain. Cryo-additives like MPD are flammable. Dispose of crystallization plates per institutional chemical waste guidelines.

Negative control: protein-free drops (buffer-only, 0.2 µL storage buffer + 0.2 µL reservoir) in spare subwells for 8-12 representative conditions to identify salt crystals and buffer-driven precipitate. Positive control: a well-behaved reference protein (e.g., hen egg-white lysozyme at 50 mg/mL against 0.1 M sodium acetate pH 4.6 / 1.0 M NaCl) set on the same plate batch to confirm reagents, plate seal, and imaging are functioning. Vehicle/buffer-matching control: a drop of storage buffer at the protein concentration's exact buffer composition to detect buffer-component crystallization.

Most drops (60-85%) will be clear or lightly precipitated. A typical good screen yields 1-8 hit conditions (5-10% hit rate) showing microcrystals, needle clusters, or single crystals within 1-14 days. Single, well-formed crystals 30-200 µm in the longest dimension with sharp edges and birefringence are ideal leads. Heavy amorphous precipitate across nearly all conditions indicates the protein is too concentrated; uniformly clear drops indicate undersaturation. Positive-control lysozyme should produce tetragonal crystals within 24-48 h.

• Purified target protein, monodisperse by SEC, in 20 mM HEPES pH 7.5, 150 mM NaCl, 1 mM TCEP; concentrated to 5 and 10 mg/mL (A280 with calculated extinction coefficient)
• Commercial sparse-matrix screen, 96 conditions (e.g., Crystal Screen HT / JCSG-plus type), deep-well block format
• 96-well sitting-drop crystallization plates with 3 subwells (e.g., MRC 3-drop or Intelli-Plate)
• Optically clear crystallization sealing film
• 0.22 µm centrifugal filters for final protein clarification
• Ultrapure water (18.2 MΩ·cm) and 0.22 µm-filtered reservoir solutions
• Reservoir volume 60-80 µL per well
• Disposable low-retention pipette tips; mosquito-compatible tip strips if using a nanodispenser

To determine reproducible initial crystallization conditions (precipitant, pH, salt, additive) for a purified soluble protein at ~10 mg/mL using a commercial 96-condition sparse-matrix screen in the sitting-drop vapor diffusion format. The output is a ranked list of hits (single crystals, microcrystals, spherulites, phase separation) suitable for grid-based optimization toward diffraction-quality crystals.

1. Thaw or freshly prepare protein; clarify by centrifugation at 16,000 x g, 10 min, 4 C, then pass through a 0.22 µm filter. Measure A280 and adjust to 5 and 10 mg/mL.
2. Transfer 60-80 µL of each of the 96 reservoir solutions into the plate reservoir wells (manual multichannel or liquid handler).
3. Using a nanodispensing robot (e.g., mosquito), dispense 0.2 µL protein + 0.2 µL reservoir into subwell 1, and 0.3 µL protein + 0.15 µL reservoir into subwell 2, for each well. Use the 10 mg/mL stock for one plate and 5 mg/mL for the duplicate plate.
4. Immediately seal each plate with optically clear film, pressing to ensure an airtight seal and avoid cross-contamination between wells.
5. Record a t = 0 image of every drop to establish the clear/precipitated baseline.
6. Incubate plates undisturbed at 18 C (and the 4 C duplicate).
7. Image all drops at 1, 3, 7, 14, and 28 days under a stereomicroscope or automated imager; score each drop (clear / precipitate / phase separation / microcrystals / spherulite / single crystal).
8. For promising hits, photograph at higher magnification and test birefringence under cross-polarized light to distinguish protein crystals from salt.
9. Confirm protein crystals with a UV imager (intrinsic Trp fluorescence) or by crushing and SDS-PAGE if ambiguous.
10. Record all hit conditions (precipitant, salt, pH, ratio, temperature) for grid optimization.

Independent: protein concentration (5 vs 10 mg/mL), reservoir composition (96 conditions), drop ratio (1:1 vs 2:1), incubation temperature (4 vs 18 C). Dependent: crystallization outcome score per drop and time-to-nucleation. Controlled: protein buffer, protein purity/monodispersity, reservoir volume, drop volume, sealing film, imaging schedule, humidity/temperature stability of incubators, single protein prep batch.

A monodisperse, properly folded protein concentrated to 8-12 mg/mL in a low-ionic-strength buffer will nucleate ordered crystals in at least one well of a broad sparse-matrix screen within 1-14 days at 18 C, and protein-containing drops will show condition-dependent outcomes distinguishable from protein-free reference drops, indicating the protein (not buffer components) drives crystal formation.

Score each drop on a standard 0-9 ordinal scale (0 = clear, 4 = phase separation, 6 = microcrystals/spherulites, 9 = large single crystal) recorded in a crystallization LIMS or spreadsheet. Build a heat map of outcome score across the 96-condition x 2-concentration x 2-temperature matrix to reveal precipitant/pH trends. Cross-reference hits against reservoir chemistry (precipitant family, pH, additive) to design follow-up grid screens. Track time-to-event for nucleation kinetics.

1. All drops clear (undersaturation): increase protein concentration to 15-20 mg/mL or screen at lower temperature. 2. Heavy precipitate everywhere (oversaturation/aggregation): lower protein concentration, re-check monodispersity by DLS/SEC, add reducing agent or a stabilizing ligand. 3. Salt crystals mistaken for protein: confirm with cross-polarized birefringence plus UV/Trp fluorescence or crush-and-SDS-PAGE; salt crystals fluoresce poorly under 280 nm. 4. Drops dried out: improve plate sealing, increase reservoir volume to 80 µL, check incubator humidity. 5. No reproducibility on re-setup: standardize protein batch, filter all solutions at 0.22 µm, and fix temperature precisely (drift of a few degrees alters supersaturation).

This is primarily a screening (discovery) experiment, so analysis is descriptive: report hit rate with a 95% Wilson confidence interval (n = 96 conditions per arm). To test whether a chemical factor (e.g., PEG vs salt precipitant) associates with hits, use Fisher's exact test on 2x2 contingency tables, alpha = 0.05, with Benjamini-Hochberg FDR correction across the precipitant-family comparisons. Temperature effect on hit count compared by McNemar's test on paired plates. No formal power calculation is standard for sparse-matrix screens; reproducibility is established by re-setting the top 3 hits in triplicate.